ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Obstructive Uropathy Treatment Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-19Y14686
Home | Market Reports | Health| Health Conditions
Global Obstructive Uropathy Treatment Market Research Report 2023
BUY CHAPTERS

Global Obstructive Uropathy Treatment Market Research Report 2025

Code: QYRE-Auto-19Y14686
Report
May 2025
Pages:88
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Boston Scientific Corporation
Olympus Corporation
Teleflex Incorporated
B Braun Melsungen AG
Applied Medical
AngioDynamics
Merit Medical Systems
Argon Medical Devices Inc
Optimed
Cook Medical
C R Bard

Obstructive Uropathy Treatment Market Size

The global market for Obstructive Uropathy Treatment was valued at US$ 5760 million in the year 2024 and is projected to reach a revised size of US$ 8066 million by 2031, growing at a CAGR of 5.0% during the forecast period.

Obstructive Uropathy Treatment Market

Obstructive Uropathy Treatment Market

Obstructive uropathy is a disorder of the urinary tract that occurs due to obstructed urinary flow and can be either structural or functional. The back-up of urine into the unilateral or bilateral kidneys, depending on the location of the obstruction, causes hydronephrosis.
North American market for Obstructive Uropathy Treatment is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Obstructive Uropathy Treatment is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Obstructive Uropathy Treatment include Boston Scientific Corporation, Olympus Corporation, Teleflex Incorporated, B. Braun Melsungen AG, Applied Medical, AngioDynamics, Merit Medical Systems, Argon Medical Devices, Inc., optimed, Cook Medical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Obstructive Uropathy Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Obstructive Uropathy Treatment.
The Obstructive Uropathy Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Obstructive Uropathy Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Obstructive Uropathy Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Obstructive Uropathy Treatment Market Report

Report Metric Details
Report Name Obstructive Uropathy Treatment Market
Accounted market size in year US$ 5760 million
Forecasted market size in 2031 US$ 8066 million
CAGR 5.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Boston Scientific Corporation, Olympus Corporation, Teleflex Incorporated, B. Braun Melsungen AG, Applied Medical, AngioDynamics, Merit Medical Systems, Argon Medical Devices, Inc., optimed, Cook Medical, C. R. Bard
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Obstructive Uropathy Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Obstructive Uropathy Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Obstructive Uropathy Treatment Market growing?

Ans: The Obstructive Uropathy Treatment Market witnessing a CAGR of 5.0% during the forecast period 2025-2031.

What is the Obstructive Uropathy Treatment Market size in 2031?

Ans: The Obstructive Uropathy Treatment Market size in 2031 will be US$ 8066 million.

Who are the main players in the Obstructive Uropathy Treatment Market report?

Ans: The main players in the Obstructive Uropathy Treatment Market are Boston Scientific Corporation, Olympus Corporation, Teleflex Incorporated, B. Braun Melsungen AG, Applied Medical, AngioDynamics, Merit Medical Systems, Argon Medical Devices, Inc., optimed, Cook Medical, C. R. Bard

What are the Application segmentation covered in the Obstructive Uropathy Treatment Market report?

Ans: The Applications covered in the Obstructive Uropathy Treatment Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Obstructive Uropathy Treatment Market report?

Ans: The Types covered in the Obstructive Uropathy Treatment Market report are Medical Treatement, Surgical Treatment

Recommended Reports

Urinary Devices Market

Urinary Treatments

Incontinence & Prostatic Care

1 Obstructive Uropathy Treatment Market Overview
1.1 Product Definition
1.2 Obstructive Uropathy Treatment by Type
1.2.1 Global Obstructive Uropathy Treatment Market Value Comparison by Type (2024 VS 2031)
1.2.2 Medical Treatement
1.2.3 Surgical Treatment
1.3 Obstructive Uropathy Treatment by Application
1.3.1 Global Obstructive Uropathy Treatment Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Obstructive Uropathy Treatment Market Size Estimates and Forecasts
1.4.1 Global Obstructive Uropathy Treatment Revenue 2020-2031
1.4.2 Global Obstructive Uropathy Treatment Sales 2020-2031
1.4.3 Global Obstructive Uropathy Treatment Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Obstructive Uropathy Treatment Market Competition by Manufacturers
2.1 Global Obstructive Uropathy Treatment Sales Market Share by Manufacturers (2020-2025)
2.2 Global Obstructive Uropathy Treatment Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Obstructive Uropathy Treatment Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Obstructive Uropathy Treatment, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Obstructive Uropathy Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Obstructive Uropathy Treatment, Product Type & Application
2.7 Global Key Manufacturers of Obstructive Uropathy Treatment, Date of Enter into This Industry
2.8 Global Obstructive Uropathy Treatment Market Competitive Situation and Trends
2.8.1 Global Obstructive Uropathy Treatment Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Obstructive Uropathy Treatment Players Market Share by Revenue
2.8.3 Global Obstructive Uropathy Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Obstructive Uropathy Treatment Market Scenario by Region
3.1 Global Obstructive Uropathy Treatment Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Obstructive Uropathy Treatment Sales by Region: 2020-2031
3.2.1 Global Obstructive Uropathy Treatment Sales by Region: 2020-2025
3.2.2 Global Obstructive Uropathy Treatment Sales by Region: 2026-2031
3.3 Global Obstructive Uropathy Treatment Revenue by Region: 2020-2031
3.3.1 Global Obstructive Uropathy Treatment Revenue by Region: 2020-2025
3.3.2 Global Obstructive Uropathy Treatment Revenue by Region: 2026-2031
3.4 North America Obstructive Uropathy Treatment Market Facts & Figures by Country
3.4.1 North America Obstructive Uropathy Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Obstructive Uropathy Treatment Sales by Country (2020-2031)
3.4.3 North America Obstructive Uropathy Treatment Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Obstructive Uropathy Treatment Market Facts & Figures by Country
3.5.1 Europe Obstructive Uropathy Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Obstructive Uropathy Treatment Sales by Country (2020-2031)
3.5.3 Europe Obstructive Uropathy Treatment Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Obstructive Uropathy Treatment Market Facts & Figures by Region
3.6.1 Asia Pacific Obstructive Uropathy Treatment Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Obstructive Uropathy Treatment Sales by Region (2020-2031)
3.6.3 Asia Pacific Obstructive Uropathy Treatment Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Obstructive Uropathy Treatment Market Facts & Figures by Country
3.7.1 Latin America Obstructive Uropathy Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Obstructive Uropathy Treatment Sales by Country (2020-2031)
3.7.3 Latin America Obstructive Uropathy Treatment Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Obstructive Uropathy Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa Obstructive Uropathy Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Obstructive Uropathy Treatment Sales by Country (2020-2031)
3.8.3 Middle East and Africa Obstructive Uropathy Treatment Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Obstructive Uropathy Treatment Sales by Type (2020-2031)
4.1.1 Global Obstructive Uropathy Treatment Sales by Type (2020-2025)
4.1.2 Global Obstructive Uropathy Treatment Sales by Type (2026-2031)
4.1.3 Global Obstructive Uropathy Treatment Sales Market Share by Type (2020-2031)
4.2 Global Obstructive Uropathy Treatment Revenue by Type (2020-2031)
4.2.1 Global Obstructive Uropathy Treatment Revenue by Type (2020-2025)
4.2.2 Global Obstructive Uropathy Treatment Revenue by Type (2026-2031)
4.2.3 Global Obstructive Uropathy Treatment Revenue Market Share by Type (2020-2031)
4.3 Global Obstructive Uropathy Treatment Price by Type (2020-2031)
5 Segment by Application
5.1 Global Obstructive Uropathy Treatment Sales by Application (2020-2031)
5.1.1 Global Obstructive Uropathy Treatment Sales by Application (2020-2025)
5.1.2 Global Obstructive Uropathy Treatment Sales by Application (2026-2031)
5.1.3 Global Obstructive Uropathy Treatment Sales Market Share by Application (2020-2031)
5.2 Global Obstructive Uropathy Treatment Revenue by Application (2020-2031)
5.2.1 Global Obstructive Uropathy Treatment Revenue by Application (2020-2025)
5.2.2 Global Obstructive Uropathy Treatment Revenue by Application (2026-2031)
5.2.3 Global Obstructive Uropathy Treatment Revenue Market Share by Application (2020-2031)
5.3 Global Obstructive Uropathy Treatment Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Boston Scientific Corporation
6.1.1 Boston Scientific Corporation Company Information
6.1.2 Boston Scientific Corporation Description and Business Overview
6.1.3 Boston Scientific Corporation Obstructive Uropathy Treatment Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Boston Scientific Corporation Obstructive Uropathy Treatment Product Portfolio
6.1.5 Boston Scientific Corporation Recent Developments/Updates
6.2 Olympus Corporation
6.2.1 Olympus Corporation Company Information
6.2.2 Olympus Corporation Description and Business Overview
6.2.3 Olympus Corporation Obstructive Uropathy Treatment Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Olympus Corporation Obstructive Uropathy Treatment Product Portfolio
6.2.5 Olympus Corporation Recent Developments/Updates
6.3 Teleflex Incorporated
6.3.1 Teleflex Incorporated Company Information
6.3.2 Teleflex Incorporated Description and Business Overview
6.3.3 Teleflex Incorporated Obstructive Uropathy Treatment Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Teleflex Incorporated Obstructive Uropathy Treatment Product Portfolio
6.3.5 Teleflex Incorporated Recent Developments/Updates
6.4 B. Braun Melsungen AG
6.4.1 B. Braun Melsungen AG Company Information
6.4.2 B. Braun Melsungen AG Description and Business Overview
6.4.3 B. Braun Melsungen AG Obstructive Uropathy Treatment Sales, Revenue and Gross Margin (2020-2025)
6.4.4 B. Braun Melsungen AG Obstructive Uropathy Treatment Product Portfolio
6.4.5 B. Braun Melsungen AG Recent Developments/Updates
6.5 Applied Medical
6.5.1 Applied Medical Company Information
6.5.2 Applied Medical Description and Business Overview
6.5.3 Applied Medical Obstructive Uropathy Treatment Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Applied Medical Obstructive Uropathy Treatment Product Portfolio
6.5.5 Applied Medical Recent Developments/Updates
6.6 AngioDynamics
6.6.1 AngioDynamics Company Information
6.6.2 AngioDynamics Description and Business Overview
6.6.3 AngioDynamics Obstructive Uropathy Treatment Sales, Revenue and Gross Margin (2020-2025)
6.6.4 AngioDynamics Obstructive Uropathy Treatment Product Portfolio
6.6.5 AngioDynamics Recent Developments/Updates
6.7 Merit Medical Systems
6.7.1 Merit Medical Systems Company Information
6.7.2 Merit Medical Systems Description and Business Overview
6.7.3 Merit Medical Systems Obstructive Uropathy Treatment Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Merit Medical Systems Obstructive Uropathy Treatment Product Portfolio
6.7.5 Merit Medical Systems Recent Developments/Updates
6.8 Argon Medical Devices, Inc.
6.8.1 Argon Medical Devices, Inc. Company Information
6.8.2 Argon Medical Devices, Inc. Description and Business Overview
6.8.3 Argon Medical Devices, Inc. Obstructive Uropathy Treatment Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Argon Medical Devices, Inc. Obstructive Uropathy Treatment Product Portfolio
6.8.5 Argon Medical Devices, Inc. Recent Developments/Updates
6.9 optimed
6.9.1 optimed Company Information
6.9.2 optimed Description and Business Overview
6.9.3 optimed Obstructive Uropathy Treatment Sales, Revenue and Gross Margin (2020-2025)
6.9.4 optimed Obstructive Uropathy Treatment Product Portfolio
6.9.5 optimed Recent Developments/Updates
6.10 Cook Medical
6.10.1 Cook Medical Company Information
6.10.2 Cook Medical Description and Business Overview
6.10.3 Cook Medical Obstructive Uropathy Treatment Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Cook Medical Obstructive Uropathy Treatment Product Portfolio
6.10.5 Cook Medical Recent Developments/Updates
6.11 C. R. Bard
6.11.1 C. R. Bard Company Information
6.11.2 C. R. Bard Description and Business Overview
6.11.3 C. R. Bard Obstructive Uropathy Treatment Sales, Revenue and Gross Margin (2020-2025)
6.11.4 C. R. Bard Obstructive Uropathy Treatment Product Portfolio
6.11.5 C. R. Bard Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Obstructive Uropathy Treatment Industry Chain Analysis
7.2 Obstructive Uropathy Treatment Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Obstructive Uropathy Treatment Production Mode & Process Analysis
7.4 Obstructive Uropathy Treatment Sales and Marketing
7.4.1 Obstructive Uropathy Treatment Sales Channels
7.4.2 Obstructive Uropathy Treatment Distributors
7.5 Obstructive Uropathy Treatment Customer Analysis
8 Obstructive Uropathy Treatment Market Dynamics
8.1 Obstructive Uropathy Treatment Industry Trends
8.2 Obstructive Uropathy Treatment Market Drivers
8.3 Obstructive Uropathy Treatment Market Challenges
8.4 Obstructive Uropathy Treatment Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Boston Scientific Corporation
Olympus Corporation
Teleflex Incorporated
B Braun Melsungen AG
Applied Medical
AngioDynamics
Merit Medical Systems
Argon Medical Devices Inc
Optimed
Cook Medical
C R Bard
List of Tables
 Table 1. Global Obstructive Uropathy Treatment Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Obstructive Uropathy Treatment Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Obstructive Uropathy Treatment Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Obstructive Uropathy Treatment Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Obstructive Uropathy Treatment Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Obstructive Uropathy Treatment Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Obstructive Uropathy Treatment Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Obstructive Uropathy Treatment Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Obstructive Uropathy Treatment, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Obstructive Uropathy Treatment, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Obstructive Uropathy Treatment, Product Type & Application
 Table 12. Global Key Manufacturers of Obstructive Uropathy Treatment, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Obstructive Uropathy Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Obstructive Uropathy Treatment as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Obstructive Uropathy Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Obstructive Uropathy Treatment Sales by Region (2020-2025) & (K Units)
 Table 18. Global Obstructive Uropathy Treatment Sales Market Share by Region (2020-2025)
 Table 19. Global Obstructive Uropathy Treatment Sales by Region (2026-2031) & (K Units)
 Table 20. Global Obstructive Uropathy Treatment Sales Market Share by Region (2026-2031)
 Table 21. Global Obstructive Uropathy Treatment Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Obstructive Uropathy Treatment Revenue Market Share by Region (2020-2025)
 Table 23. Global Obstructive Uropathy Treatment Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Obstructive Uropathy Treatment Revenue Market Share by Region (2026-2031)
 Table 25. North America Obstructive Uropathy Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Obstructive Uropathy Treatment Sales by Country (2020-2025) & (K Units)
 Table 27. North America Obstructive Uropathy Treatment Sales by Country (2026-2031) & (K Units)
 Table 28. North America Obstructive Uropathy Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Obstructive Uropathy Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Obstructive Uropathy Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Obstructive Uropathy Treatment Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Obstructive Uropathy Treatment Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Obstructive Uropathy Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Obstructive Uropathy Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Obstructive Uropathy Treatment Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Obstructive Uropathy Treatment Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Obstructive Uropathy Treatment Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Obstructive Uropathy Treatment Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Obstructive Uropathy Treatment Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Obstructive Uropathy Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Obstructive Uropathy Treatment Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Obstructive Uropathy Treatment Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Obstructive Uropathy Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Obstructive Uropathy Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Obstructive Uropathy Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Obstructive Uropathy Treatment Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Obstructive Uropathy Treatment Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Obstructive Uropathy Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Obstructive Uropathy Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Obstructive Uropathy Treatment Sales (K Units) by Type (2020-2025)
 Table 51. Global Obstructive Uropathy Treatment Sales (K Units) by Type (2026-2031)
 Table 52. Global Obstructive Uropathy Treatment Sales Market Share by Type (2020-2025)
 Table 53. Global Obstructive Uropathy Treatment Sales Market Share by Type (2026-2031)
 Table 54. Global Obstructive Uropathy Treatment Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Obstructive Uropathy Treatment Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Obstructive Uropathy Treatment Revenue Market Share by Type (2020-2025)
 Table 57. Global Obstructive Uropathy Treatment Revenue Market Share by Type (2026-2031)
 Table 58. Global Obstructive Uropathy Treatment Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Obstructive Uropathy Treatment Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Obstructive Uropathy Treatment Sales (K Units) by Application (2020-2025)
 Table 61. Global Obstructive Uropathy Treatment Sales (K Units) by Application (2026-2031)
 Table 62. Global Obstructive Uropathy Treatment Sales Market Share by Application (2020-2025)
 Table 63. Global Obstructive Uropathy Treatment Sales Market Share by Application (2026-2031)
 Table 64. Global Obstructive Uropathy Treatment Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Obstructive Uropathy Treatment Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Obstructive Uropathy Treatment Revenue Market Share by Application (2020-2025)
 Table 67. Global Obstructive Uropathy Treatment Revenue Market Share by Application (2026-2031)
 Table 68. Global Obstructive Uropathy Treatment Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Obstructive Uropathy Treatment Price (US$/Unit) by Application (2026-2031)
 Table 70. Boston Scientific Corporation Company Information
 Table 71. Boston Scientific Corporation Description and Business Overview
 Table 72. Boston Scientific Corporation Obstructive Uropathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Boston Scientific Corporation Obstructive Uropathy Treatment Product
 Table 74. Boston Scientific Corporation Recent Developments/Updates
 Table 75. Olympus Corporation Company Information
 Table 76. Olympus Corporation Description and Business Overview
 Table 77. Olympus Corporation Obstructive Uropathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Olympus Corporation Obstructive Uropathy Treatment Product
 Table 79. Olympus Corporation Recent Developments/Updates
 Table 80. Teleflex Incorporated Company Information
 Table 81. Teleflex Incorporated Description and Business Overview
 Table 82. Teleflex Incorporated Obstructive Uropathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Teleflex Incorporated Obstructive Uropathy Treatment Product
 Table 84. Teleflex Incorporated Recent Developments/Updates
 Table 85. B. Braun Melsungen AG Company Information
 Table 86. B. Braun Melsungen AG Description and Business Overview
 Table 87. B. Braun Melsungen AG Obstructive Uropathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. B. Braun Melsungen AG Obstructive Uropathy Treatment Product
 Table 89. B. Braun Melsungen AG Recent Developments/Updates
 Table 90. Applied Medical Company Information
 Table 91. Applied Medical Description and Business Overview
 Table 92. Applied Medical Obstructive Uropathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Applied Medical Obstructive Uropathy Treatment Product
 Table 94. Applied Medical Recent Developments/Updates
 Table 95. AngioDynamics Company Information
 Table 96. AngioDynamics Description and Business Overview
 Table 97. AngioDynamics Obstructive Uropathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. AngioDynamics Obstructive Uropathy Treatment Product
 Table 99. AngioDynamics Recent Developments/Updates
 Table 100. Merit Medical Systems Company Information
 Table 101. Merit Medical Systems Description and Business Overview
 Table 102. Merit Medical Systems Obstructive Uropathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Merit Medical Systems Obstructive Uropathy Treatment Product
 Table 104. Merit Medical Systems Recent Developments/Updates
 Table 105. Argon Medical Devices, Inc. Company Information
 Table 106. Argon Medical Devices, Inc. Description and Business Overview
 Table 107. Argon Medical Devices, Inc. Obstructive Uropathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Argon Medical Devices, Inc. Obstructive Uropathy Treatment Product
 Table 109. Argon Medical Devices, Inc. Recent Developments/Updates
 Table 110. optimed Company Information
 Table 111. optimed Description and Business Overview
 Table 112. optimed Obstructive Uropathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. optimed Obstructive Uropathy Treatment Product
 Table 114. optimed Recent Developments/Updates
 Table 115. Cook Medical Company Information
 Table 116. Cook Medical Description and Business Overview
 Table 117. Cook Medical Obstructive Uropathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Cook Medical Obstructive Uropathy Treatment Product
 Table 119. Cook Medical Recent Developments/Updates
 Table 120. C. R. Bard Company Information
 Table 121. C. R. Bard Description and Business Overview
 Table 122. C. R. Bard Obstructive Uropathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. C. R. Bard Obstructive Uropathy Treatment Product
 Table 124. C. R. Bard Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Obstructive Uropathy Treatment Distributors List
 Table 128. Obstructive Uropathy Treatment Customers List
 Table 129. Obstructive Uropathy Treatment Market Trends
 Table 130. Obstructive Uropathy Treatment Market Drivers
 Table 131. Obstructive Uropathy Treatment Market Challenges
 Table 132. Obstructive Uropathy Treatment Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Obstructive Uropathy Treatment
 Figure 2. Global Obstructive Uropathy Treatment Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Obstructive Uropathy Treatment Market Share by Type: 2024 & 2031
 Figure 4. Medical Treatement Product Picture
 Figure 5. Surgical Treatment Product Picture
 Figure 6. Global Obstructive Uropathy Treatment Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Obstructive Uropathy Treatment Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Others
 Figure 11. Global Obstructive Uropathy Treatment Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Obstructive Uropathy Treatment Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Obstructive Uropathy Treatment Sales (2020-2031) & (K Units)
 Figure 14. Global Obstructive Uropathy Treatment Average Price (US$/Unit) & (2020-2031)
 Figure 15. Obstructive Uropathy Treatment Report Years Considered
 Figure 16. Obstructive Uropathy Treatment Sales Share by Manufacturers in 2024
 Figure 17. Global Obstructive Uropathy Treatment Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Obstructive Uropathy Treatment Players: Market Share by Revenue in Obstructive Uropathy Treatment in 2024
 Figure 19. Obstructive Uropathy Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Obstructive Uropathy Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Obstructive Uropathy Treatment Sales Market Share by Country (2020-2031)
 Figure 22. North America Obstructive Uropathy Treatment Revenue Market Share by Country (2020-2031)
 Figure 23. United States Obstructive Uropathy Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Obstructive Uropathy Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Obstructive Uropathy Treatment Sales Market Share by Country (2020-2031)
 Figure 26. Europe Obstructive Uropathy Treatment Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Obstructive Uropathy Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Obstructive Uropathy Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Obstructive Uropathy Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Obstructive Uropathy Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Obstructive Uropathy Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Obstructive Uropathy Treatment Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Obstructive Uropathy Treatment Revenue Market Share by Region (2020-2031)
 Figure 34. China Obstructive Uropathy Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Obstructive Uropathy Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Obstructive Uropathy Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Obstructive Uropathy Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Obstructive Uropathy Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Obstructive Uropathy Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Obstructive Uropathy Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Obstructive Uropathy Treatment Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Obstructive Uropathy Treatment Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Obstructive Uropathy Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Obstructive Uropathy Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Obstructive Uropathy Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Obstructive Uropathy Treatment Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Obstructive Uropathy Treatment Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Obstructive Uropathy Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Obstructive Uropathy Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Obstructive Uropathy Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Obstructive Uropathy Treatment by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Obstructive Uropathy Treatment by Type (2020-2031)
 Figure 53. Global Obstructive Uropathy Treatment Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Obstructive Uropathy Treatment by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Obstructive Uropathy Treatment by Application (2020-2031)
 Figure 56. Global Obstructive Uropathy Treatment Price (US$/Unit) by Application (2020-2031)
 Figure 57. Obstructive Uropathy Treatment Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Renal Insufficiency Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nephrology Stents And Catheters Market Research Report 2024
Global Urinary Incontinence Market Research Report 2024
Global Ureteral Stent System Market Research Report 2024
BPH Treatment Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nephrology and Urology Incontinence Device Market Research Report 2024
Non Surgical Urinary Incontinence Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Transurethral Resection Of The Prostate Market Research Report 2024
Global Implanted Urinary Incontinence Device Market Research Report 2025
Global Polymer Ureteral Stents Market Research Report 2024
Incontinence Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Men s Urinary Incontinence Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Adult Urinary Incontinence Treatment Device Market Research Report 2025
Global End Stage Kidney Disease Market Research Report 2024
Global Renal Diseases Drug Market Insights Forecast to 2030
Global Double Loop Ureteral Stent Market Research Report 2025
Global Benign Prostatic Hyperplasia BPH Treatment Market Research Report 2024
Global End Stage Renal Disease Market Research Report 2024
Global Renal Therapeutic Market Research Report 2025
Global Incontinence Care Products and Devices Market Insights Forecast to 2030

RELATED REPORTS

Global Coronary Imaging Catheter Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32P14840
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Digital Platform for Chronic Kidney Disease (CKD) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20V18395
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Continuous Glucose Monitoring Sensor Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32G20014
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Radioactive Iodine Ablation Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9U20281
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions